Gene · 6472
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | Nucleic Acids Res | 2022 | 35687106 | PubTator, text mining | PubMed |
| Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis. | Proteome Sci | 2022 | 35681168 | PubTator, text mining | PubMed |
| Single-cell sequencing analysis reveals gastric cancer microenvironment cells respond vastly different to oxidative stress. | J Transl Med | 2022 | 35659682 | PubTator, text mining | PubMed |
| Global DNA hypomethylation of colorectal tumours detected in tissue and liquid biopsies may be related to decreased methyl-donor content. | BMC Cancer | 2022 | 35655145 | PubTator, text mining | PubMed |
| A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. | Nat Cell Biol | 2022 | 35654839 | PubTator, text mining | PubMed |
| Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension. | Front Med (Lausanne) | 2022 | 35646965 | PubTator, text mining | PubMed |
| Pharmacologic modulation of 5-fluorouracil by folinic acid and pyridoxine for treatment of patients with advanced breast carcinoma. | Sci Rep | 2022 | 35641554 | PubTator, text mining | PubMed |
| Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma. | J Hepatol | 2022 | 35636578 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers. | Nutrients | 2022 | 35631199 | PubTator, text mining | PubMed |
| Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 35626154 | PubTator, text mining | PubMed |
| New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming. | J Exp Clin Cancer Res | 2022 | 35619118 | PubTator, text mining | PubMed |
| Deubiquitinases in cell death and inflammation. | Biochem J | 2022 | 35608338 | PubTator, text mining | PubMed |
| Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2. | iScience | 2022 | 35602963 | PubTator, text mining | PubMed |
| Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells. | Sci Adv | 2022 | 35594343 | PubTator, text mining | PubMed |
| Role of sirtuins in esophageal cancer: Current status and future prospects. | World J Gastrointest Oncol | 2022 | 35582109 | PubTator, text mining | PubMed |
| Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis. | Nat Commun | 2022 | 35577770 | PubTator, text mining | PubMed |
| Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells. | Front Cell Infect Microbiol | 2022 | 35573784 | PubTator, text mining | PubMed |
| The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications. | Front Pharmacol | 2022 | 35571098 | PubTator, text mining | PubMed |
| Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells. | Biomaterials | 2022 | 35567999 | PubTator, text mining | PubMed |
| Serine Metabolism in Health and Disease and as a Conditionally Essential Amino Acid. | Nutrients | 2022 | 35565953 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6472/papers?page=26